๐ฐ Cinrx Pharma News
Page 2 - Cinrx Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cinrx Pharma. Real-time updates on events, politics, business and more.
July 25, 2022
VTv Therapeutics Announces Investment by CinRx Pharma HIGH POINT, N.C.--July 25, 2022 - vTv Therapeutics Inc. today announced entry into agreements that include... | July 25, 2022
April 11, 2022
Increasing cases of Inflammatory Bowel Disease (IBD) in various regions lead to increased demand for advanced diagnostic and treatment in the Inflammatory...
January 8, 2022
Itโs the first week of the new year, and the life sciences sector continued the IPO momentum of 2021 as Wall Street welcomed three new biotech companies. Hereโs a look at the IPOs of Amylyx Pharmaceuticals, CinCor, and Vigil Neuroscience, which raised a combined $482 million to support work on drugs addressing neurodegenerative and cardiovascular disorders.
October 26, 2021
/PRNewswire/ -- DelveInsights Ulcerative Colitis Market report offers a detailed comprehension of the Ulcerative Colitis market size by treatment,...
October 26, 2021
/PRNewswire/ -- DelveInsights Ulcerative Colitis Market report offers a detailed comprehension of the Ulcerative Colitis market size by treatment,...
October 26, 2021
Targeted therapies such as Interleukin and JAK inhibitors are making inroads into the Ulcerative Colitis market owing to better clinical profile and also patient convenient dosing LAS VEGAS
May 6, 2021
Share this article Share this article ResearchAndMarkets.coms offering. According to this report the market is expected to reach US$ 6,025.11 million by 2027 from US$ 4,338.61 million in 2019; it is estimated to grow at a CAGR of 4.3% from 2020 to 2027. The report highlights trends prevailing in the market, and the factors driving and hindering the market growth. The market growth is primarily attributed to the increasing diabetes prevalence and growing geriatric population. However, side-effe...